Depression and anxiety in pregnant women
Authors:
D. Seifertová 1,2; P. Mohr 1,2; J. Praško 1,3; J. Čermák 1,2
Authors‘ workplace:
Psychiatrické centrum, Praha
Ředitel: prof. MUDr. Cyril Hoschl, DrSc.
1; Univerzita Karlova, Praha
3. lékařská fakulta
Přednosta: prof. MUDr. Cyril Hoschl, DrSc.
2; Fakultní nemocnice Olomouc
Psychiatrická klinika
Přednosta: doc. MUDr. Ján Praško, CSc.
3
Published in:
Prakt. Lék. 2009; 89(9): 508-513
Category:
Therapy
Overview
The general practitioner frequently sees pregnant females with anxiety and depressive symptoms and has to decide about treatment. Therefore it is essential to become familiar with the principles of drug treatment in pregnancy and breast-feeding and to know the risks and benefits. We have to decide whether to treat with psychotherapy, alternative therapies or pharmacotherapy. The basic principles of the drug treatment of anxiety and depressive disorders during pregnancy and breast-feeding are reviewed. We emphasize interdisciplinary cooperation between the gynaecologist, general practitioner, obstetrician, neonatologist and geneticist.
Key words:
pregnancy, breast-feeding, anxiety disorders, depressive disorders, psychotropics.
Sources
1. Mohr, P. Psychofarmaka v ordinaci praktického lékař podávaná v těhotenství a v laktaci. Prakt. Lék. 2007. 87. s. 11-16.
2. Mohr, P., Praško, J., Bareš, M. a kol. Psychické poruchy v graviditě a laktaci. In: Seifertová D., Praško J., Horáček J., Hoschl C. Postupy v léčbě psychických poruch. Academia Medica Pragensis a Medical Tribune, 2008, s. 483-493.
3. Bareš, M. Antidepresiva v léčbě depresivní poruchy v těhotenství a po porodu. Psychiatrie 2002, suppl. 2, s. 6–11.
4. Cohen, L.S., Altshuler, L.L., Harlow, B.L. et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006, 295, p. 499–507.
5. MacGabe, J.H., Martinsson, L., Lichtenstein, P. et al. Averse pregnancy outcomes in mothers with affective psychosis. Bipolar. Disord. 2007, 9, p. 305–309.
6. Gotlib, I.H., Whiffen, V.E., Mount, H. et al. Prevalence rates and demografic charcteristics associated with depression in pregnancy and the postpartum. J. Consult. Clin. Psychol. 1989, 57, p. 269–274.
7. Praško, J. Psychoterapie poporodních depresí. Psychiatrie 2002, 6 (suppl. 2), s. 39-44.
8. Oberlander, T.F., Warburton, W., Misri, S. et al. Major congenital malformation following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based linked health data. Birth Defects Res. B. Dev. Reprod. Toxicol. 2008, 83, p. 68–76.
9. Ramos, E., St-André, M., Rey, E. et al. Duration of antidepressant use during pregnancy and risk of major congenital malformations. Br. J. Psychiatry 2008, 192, p. 344–350.
10. Bérard, A., Ramos, E., Rey, E. et al. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importace of dosage. Birth Defects Res. B. Dev. Reprod. Toxicol. 2007, 80, p. 18–27.
11. Colem J.A., Ephross, S.A., Cosmatos, I.S., Walker, A.M. Paroxetine in the first trimester and the prevalence of congenital malformations. Pharmacoepidemiol. Drug Saf. 2007, 16, p. 1075 až 1085.
12. Cole, J.A., Modell, J.G., Haight, B.R. et al. Bupropion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol. Drug Saf. 2007, 16, p. 474-484.
13. Suri, R., Altshuler, L.L., Hellemann, G. et al. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am. J. Psychiatry 2007, 164, p. 1206-1213.
14. Oberlander, T.F., Warburton, W., Misri, S. et al. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch. Gen. Psychiatry 2006, 63, p. 898-906.
15. Oberlander, T.F., Warburton, W., Misri, S. et al. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants. Population based study. Br. J. Psychiatry 2008, 192, p. 338–343.
16. Chambers, C.D., Hernandez-Diaz, S. Van Marten, L.J. et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of newborn. NEJM 2006, 354, p. 379-387.
17. Halberg, P., Sjoblom, V. The use of serotonin-reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects. J. Clin. Psychopharmacol. 2005, 25, p. 59-73.
18. Klirova, M., Novak, T., Kopeček, M. et al. Repetitive transcranial magnetic stimulation (rTMS) in major depressive episode during pregnancy. Neuroendocrinol. Lett. 2008, 29, p. 69-70.
19. Seifertová, D. Elektrokonvulze v těhotenství. Psychiatrie 2002, suppl 2, s. 82-83.
20. Praško, J., Kosová, J., Herman, E. Psychoterapie úzkostných poruch v těhotenství a poporodním období. Psychiatrie 2002, suppl. 2, s. 47-57.
21. Altshuler, L., Cohen, L., Szuba, M.P. et al. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am. J. Psychiatry 1996, 153, p. 592-606.
22. Dolovich, L.R., Addis, A., Vaillancourt, J.M. et al. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-anylysis of cohort and case-control studies. BMJ 1998, 317, p. 839-843.
23. Wikner, B.N., Stiller, C.O., Bergman, U. et al. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy : neonatal outcome and congenital malformations. Pharmacoepidemiol. Drug Saf. 2007, 16, p. 1203-1210.
24. American Academy of Pediatrics, Committe on Drugs. Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Pediatrics 2000; 105, p. 880-887.
25. Cohen, L.S., Rosenbaum, J.F. Psychotropic drug use in pregnancy: weighing the risks. J. Clin. Psychiatry 1998, 59 (suppl. 2), p. 18-28.
26. Arnon, J., Schechtman, S., Ornoy, A. The use of psychiatric drugs in pregnancy and lactation. J. Psychiatry Relat. Sci. 2000, 37, p. 205-222.
27. Seifertová, D., Čepický, P., Strunzová, V. a kol. Diagnostika a léčba psychických poruch v gynekologii, při těhotenství a laktaci. In: Konsiliární psychiatrie. Praha: Galén, Medical Tribune, 2007, s. 368-377.
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
2009 Issue 9
Most read in this issue
- Depression and anxiety in pregnant women
- Deliberate self-harm – a serious symptom and dangerous social phenomenon
- Dementia in a general practitioner‘s office
- Echocardiography and anticoagulation treatment of patients with cardioembolic stroke